Sandwell and West Birmingham Hospitals NHS Trust Sandwell and West Birmingham Clinical Commissioning Group Formulary The drugs contained in the formulary of Sandwell and West Birmingham Hospitals Trust are listed below. NICE considers that the benefits of a local formulary include • improving patient outcomes by optimising the use of medicines; • supporting the inclusion of patient factors in decision-making about medicines; • improving local care pathways; • improving collaboration between clinicians and commissioners; • improving quality by reducing inappropriate variations in clinical care; • improving quality through access to cost-effective medicines; • supporting the supply arrangements of medicines across a local health economy; • supporting financial management and expenditure on medicines across health communities; • supporting prescribers to follow guidance published by professional regulatory bodies in relation to medicines and prescribing. Drugs marked in black text are available for general use and may be prescribed by any prescriber in the Trust Drugs marked in orange as “restricted” are available for use in restricted circumstances; they may be restricted to certain specialties, or for treating certain diseases, or for use when first-line treatment has not worked. Where clinically appropriate, prescribing of restricted drugs may be passed to primary care on the advice of a specialist. Drugs which are approved by NICE in a technology appraisal are available for use in the Trust. All other drugs are available on Consultant request provided the request is authorized by a medical director or an officer of the Drug and Therapeutics committee. This formulary was published on 8th January 2014 Formulary Sec tion Title Status 1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->Aluminium- and magnesium-containing antacids ALUMINIUM HYDROXIDE On Formulary 1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->Aluminium- and magnesium-containing antacids MAGNESIUM TRISILICATE On Formulary 1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->Aluminium- and magnesium-containing antacids->ALUMINIUM HYDROXIDE Co-magaldrox On Formulary 1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->Aluminium- and magnesium-containing antacids->ALUMINIUM HYDROXIDE->Co- magaldrox Maalox® On Formulary 1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->Aluminium- and magnesium-containing antacids->MAGNESIUM TRISILICATE Magnesium Trisilicate Mixture, BP On Formulary 1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->Simeticone alone Infacol® Restricted 1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2 Compound alginates and proprietary indigestion preparations->Alginate raft-forming oral suspensions Peptac® On Formulary 1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2 Compound alginates and proprietary indigestion preparations->Other compound alginate preparations Gaviscon Infant® Restricted 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility Motility stimulants On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Antimuscarinics ATROPINE SULFATE On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Antimuscarinics HYOSCINE BUTYLBROMIDE On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Antimuscarinics->ATROPINE SULFATE Atropine On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Antimuscarinics->HYOSCINE BUTYLBROMIDE Buscopan® On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Other antispasmodics MEBEVERINE HYDROCHLORIDE On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Other antispasmodics PEPPERMINT OIL On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Other antispasmodics->MEBEVERINE HYDROCHLORIDE Mebeverine Hydrochloride On Formulary 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists RANITIDINE On Formulary 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists->RANITIDINE Ranitidine On Formulary 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.4 Prostaglandin analogues MISOPROSTOL Restricted This formulary was published on 8th January 2014 Formulary Sec tion Title Status 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors LANSOPRAZOLE On Formulary 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors OMEPRAZOLE Restricted 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->LANSOPRAZOLE Lansoprazole On Formulary 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->LANSOPRAZOLE Zoton® Restricted 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->OMEPRAZOLE Omeprazole On Formulary 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->OMEPRAZOLE Losec® Restricted 1 Gastro-intestinal system->1.4 Acute diarrhoea->1.4.2 Antimotility drugs CODEINE PHOSPHATE On Formulary 1 Gastro-intestinal system->1.4 Acute diarrhoea->1.4.2 Antimotility drugs LOPERAMIDE HYDROCHLORIDE On Formulary 1 Gastro-intestinal system->1.4 Acute diarrhoea->1.4.2 Antimotility drugs MORPHINE On Formulary 1 Gastro-intestinal system->1.4 Acute diarrhoea->1.4.2 Antimotility drugs->LOPERAMIDE HYDROCHLORIDE Imodium® On Formulary 1 Gastro-intestinal system->1.4 Acute diarrhoea->1.4.2 Antimotility drugs->LOPERAMIDE HYDROCHLORIDE Loperamide On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates MESALAZINE On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates SULFASALAZINE On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates BALSALAZIDE SODIUM Restricted 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->BALSALAZIDE SODIUM Colazide® Restricted 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Asacol® On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Asacol® MR On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Pentasa® On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Salofalk® On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->SULFASALAZINE Sulfasalazine On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.2 Corticosteroids PREDNISOLONE On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.2 Corticosteroids BUDESONIDE Restricted 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.2 Corticosteroids->PREDNISOLONE->Rectal preparations Predsol® On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response AZATHIOPRINE Restricted 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->Cytokine modulators ADALIMUMAB Restricted 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->Cytokine modulators- >INFLIXIMAB Preparations Restricted This formulary was published on 8th January 2014 Formulary Sec tion Title Status 1 Gastro-intestinal system->1.6 Laxatives->1.6.1 Bulk-forming laxatives ISPAGHULA HUSK On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.1 Bulk-forming laxatives METHYLCELLULOSE On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives DOCUSATE SODIUM On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives GLYCEROL On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives SENNA On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives SODIUM PICOSULFATE On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives DANTRON Restricted 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- With docusate sodium (as co- >DANTRON danthrusate) Restricted 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- With poloxamer ?188? (as co- >DANTRON danthramer) Restricted 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- >DANTRON->With docusate sodium (as co-danthrusate) Co-danthrusate Restricted 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- >DANTRON->With poloxamer ?188? (as co-danthramer) Co-danthramer Restricted 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- >GLYCEROL Glycerol Suppositories, BP On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.2